Picture of Polypid logo

PYPD Polypid Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Polypid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.91-36.9-42.6-39.6-23.9
Depreciation
Non-Cash Items-10.415.94.754.64.92
Other Non-Cash Items
Changes in Working Capital-1.01-1.694.35-1.08-0.11
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-17.4-21.6-32.4-34.3-17.2
Capital Expenditures-0.879-0.781-2.65-1.77-0.196
Purchase of Fixed Assets
Other Investing Cash Flow Items-22.7-4039.618.34
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-23.6-40.836.916.63.8
Financing Cash Flow Items-0.125
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities37.762.81.0316.49.98
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.270.415.55-1.31-3.46